DK0710482T3 - Terapeutisk middel mod myocardiale iskæmiske skader eller reperfusionsskader - Google Patents

Terapeutisk middel mod myocardiale iskæmiske skader eller reperfusionsskader

Info

Publication number
DK0710482T3
DK0710482T3 DK95116989T DK95116989T DK0710482T3 DK 0710482 T3 DK0710482 T3 DK 0710482T3 DK 95116989 T DK95116989 T DK 95116989T DK 95116989 T DK95116989 T DK 95116989T DK 0710482 T3 DK0710482 T3 DK 0710482T3
Authority
DK
Denmark
Prior art keywords
therapeutic agent
reperfusion injuries
compound
myocardial ischemic
myocardial
Prior art date
Application number
DK95116989T
Other languages
Danish (da)
English (en)
Inventor
Yasushi Abiko
Hiroko Hashizume
Akiyoshi Hara
Yoichi Yamauchi
Junichi Kawagoe
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Application granted granted Critical
Publication of DK0710482T3 publication Critical patent/DK0710482T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK95116989T 1994-11-02 1995-10-27 Terapeutisk middel mod myocardiale iskæmiske skader eller reperfusionsskader DK0710482T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26950394 1994-11-02

Publications (1)

Publication Number Publication Date
DK0710482T3 true DK0710482T3 (da) 1999-08-30

Family

ID=17473336

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95116989T DK0710482T3 (da) 1994-11-02 1995-10-27 Terapeutisk middel mod myocardiale iskæmiske skader eller reperfusionsskader

Country Status (6)

Country Link
US (1) US5602123A (enExample)
EP (1) EP0710482B1 (enExample)
AT (1) ATE175351T1 (enExample)
DE (1) DE69507113T2 (enExample)
DK (1) DK0710482T3 (enExample)
ES (1) ES2127983T3 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997007806A1 (en) * 1995-08-29 1997-03-06 Kowa Co., Ltd. Preventive or remedy for kidney diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1452413A (enExample) * 1973-08-16 1976-10-13 Fuji Chem Ind Co Ltd
JP2722250B2 (ja) * 1989-05-30 1998-03-04 興和株式会社 新規なジアミン化合物及びこれを含有する脳機能障害改善剤

Also Published As

Publication number Publication date
ES2127983T3 (es) 1999-05-01
ATE175351T1 (de) 1999-01-15
DE69507113D1 (de) 1999-02-18
EP0710482A3 (enExample) 1996-05-22
EP0710482A2 (en) 1996-05-08
EP0710482B1 (en) 1999-01-07
US5602123A (en) 1997-02-11
DE69507113T2 (de) 1999-05-27

Similar Documents

Publication Publication Date Title
CY1111951T1 (el) Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου
EP0236140A3 (en) Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives
TR200201059T2 (tr) Kardiyak arritmialarının tedavisinde kullanışlı yeni oksabispidin bileşimleri
KR910000620A (ko) N-치환 라우르아미드, 그의 제조방법 및 조성물
DE69326395D1 (de) Spirooxathiolan-quinuclidin-Derivat zur Behandlung des Sjögren-Syndroms
RU94045271A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера
DK0420121T3 (da) Antitumormiddel
NZ501492A (en) Di-amine and tetra-amine derivatives and pharmaceuticals thereof, useful for treating cardiac arrhythmia
KR950703341A (ko) 항부정맥제
DK0710482T3 (da) Terapeutisk middel mod myocardiale iskæmiske skader eller reperfusionsskader
MX9206930A (es) Nuevos compuestos
ATE341318T1 (de) Verwendung eines mittels zur verbesserung der astrozytenfunktion zur behandlung von parkinsons krankheit
ATE63541T1 (de) N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel.
KR960003719A (ko) 녹내장 치료제 및 안압 강하제
DK638787D0 (da) Anthracyclinderivater, deres fremstilling og anvendelse
ATE86117T1 (de) Zusammensetzung gegen leberkrankheiten.
NO20003138L (no) Ny anvendelse av lokalanestetika mot vaskulære hodepiner
DK0876144T3 (da) Terapeutiske anti-astmamidler indeholdende organiske selenforbindelser
ATE168690T1 (de) Indolderivate, ihre salze und sie enthaltende arzneimittel zur behandlung von herzkrankheiten
NZ237400A (en) Amino and quaternary ammonium derivatives of ascorbic acid; use in combating reperfusion damage
EP1325918A4 (en) INHIBITORS OF CARDIAC MUSCLE CELL APOPTOSIS AND THERAPEUTIC / PROPHYLACTIC AGENTS AGAINST HEART DISEASE
KR940021524A (ko) 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법
RU2001130750A (ru) Замещенные триптофансодержащие дипептиды с холецистокининонегативной или холецистокининопозитивной активностью
ATE243219T1 (de) 9a, 11b-dehydro derivative von 9-oxime-3-keto-6-0-methylerythromycin
DE69532963D1 (de) Verwendung von 4-acylaminopyridin derivaten zur Herstellung eines Medikaments für die Behandlung von zerebrovaskulären Erkrankungen